Screener
Celldex Therapeutics CLDX PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by Celldex Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: Celldex Therapeutics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091984
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Accounts and other receivables | 230 | 2,015 |
| Prepaid and other current assets | 7,114 | 14,076 |
| Total current assets | 724,931 | 534,664 |
| Property and equipment, net | 9,756 | 5,334 |
| Operating lease right-of-use assets, net | 5,038 | 2,437 |
| Intangible assets | 27,190 | 27,190 |
| Other assets | 15,434 | 13,358 |
| Total assets | $782,349 | $582,983 |
Item 1. Unaudited Financial Statements
FAQ
- What is Celldex Therapeutics's PP&E (net)?
- Celldex Therapeutics (CLDX) reported PP&E (net) of $9.76M in Q2 2026.
- How has Celldex Therapeutics's PP&E (net) changed year-over-year?
- Celldex Therapeutics's PP&E (net) increased by 122.1% year-over-year, from $4.39M to $9.76M.
- What is the long-term trend for Celldex Therapeutics's PP&E (net)?
- Over 5 years (2020 to 2025), Celldex Therapeutics's PP&E (net) has grown at a 6.9% compound annual growth rate (CAGR), from $3.82M to $5.33M.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about Celldex Therapeutics's pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude